Literature DB >> 18324406

Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy.

M Cosottini1, C Tavarelli, L Del Bono, G Doria, M Giannelli, S De Cori, M C Michelassi, C Bartolozzi, L Murri.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease of the central nervous system due to JC polyoma virus infection of oligodendrocytes. PML develops in patients with impaired T-cell function as occurs in HIV, malignancy or immunosuppressive drugs users. Until now no imaging methods have been reported to correlate with clinical status. Diffusion-weighted imaging (DWI) is a robust MRI tool in investigating white matter architecture and diseases. The aim of our work was to assess diffusion abnormalities in focal white matter lesions in patients with PML and to correlate the lesion load measured with conventional MRI and DWI to clinical variables. We evaluated eight patients with a biopsy or laboratory-supported diagnosis of PML. All patients underwent MRI including conventional sequences (fluid attenuated inversion recovery-FLAIR) and DWI. Mean diffusivity (MD) maps were used to quantify diffusion on white matter lesions. Global lesion load was calculated by manually tracing lesions on FLAIR images, while total, central core and peripheral lesion loads were calculated by manually tracing lesions on DWI images. Lesion load obtained with the conventional or DWI-based methods were correlated with clinical variables such as disease duration, disease severity and survival. White matter focal lesions are characterized by a central core with low signal on DWI images and high MD (1.853 x 10(-3) mm2/s), surrounded by a rim of high signal intensity on DWI and lower MD (1.1 x 10(-3) mm2/s). The MD value of normal-appearing white matter is higher although not statistically significant (0.783 x 10(-3) mm2/s) with respect to control subjects (0.750 x 10(-3) mm2/s). Inter-rater correlations of global lesion load between FLAIR (3.96%) and DWI (3.43%) was excellent (ICC=0.87). Global lesion load on FLAIR and DWI correlates with disease duration and severity (respectively, p=0.037, p=0.0272 with Karnofsky scale and p=0.0338 with EDSS on FLAIR images; p=0.043, p=0.0296 with Karnofsky scale and p=0.0365 with EDSS on DW images). Central core lesion load on DWI correlates with disease duration and severity (respectively p=0.043, p=0.0103 with Karnofsky scale and p=0.0112 with EDSS), while peripheral lesion load does not correlate with any clinical variable. The global lesion load in PML correlates with disease duration and severity. DWI images, which can distinguish within lesions a central core from a peripheral rim, reveal that a larger central core component correlates to a worsened clinical status and longer disease duration. On the other hand the peripheral rim lesion load visualized on DWI images does not correlate with clinical variables and does not achieve obtaining further prognostic information with respect to conventional imaging.

Entities:  

Mesh:

Year:  2008        PMID: 18324406     DOI: 10.1007/s00330-007-0845-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


  29 in total

1.  Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study.

Authors:  A De Luca; M L Giancola; A Ammassari; S Grisetti; A Cingolani; D Larussa; L Alba; R Murri; G Ippolito; R Cauda; A Monforte; A Antinori
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 2.  Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare.

Authors:  J R Berger; M Concha
Journal:  J Neurovirol       Date:  1995-03       Impact factor: 2.643

3.  Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI.

Authors:  I Mader; U Herrlinger; U Klose; F Schmidt; W Küker
Journal:  Neuroradiology       Date:  2003-08-27       Impact factor: 2.804

4.  The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy.

Authors:  Eric Lewin Altschuler; Richard E Kast
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

5.  Conventional and diffusion-weighted MRI in progressive multifocal leukoencephalopathy: new elements for identification and follow-up.

Authors:  S da Pozzo; R Manara; S Tonello; C Carollo
Journal:  Radiol Med       Date:  2006-10-11       Impact factor: 3.469

6.  Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy.

Authors:  A De Luca; M L Giancola; A Cingolani; A Ammassari; L Gillini; R Murri; A Antinori
Journal:  Clin Infect Dis       Date:  1999-03       Impact factor: 9.079

7.  Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images.

Authors:  M Rovaris; M Filippi; G Calori; M Rodegher; A Campi; B Colombo; G Comi
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

8.  Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging.

Authors:  T Ernst; L Chang; M Witt; I Walot; H Aronow; M Leonido-Yee; E Singer
Journal:  Radiology       Date:  1999-02       Impact factor: 11.105

Review 9.  Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  E O Major; K Amemiya; C S Tornatore; S A Houff; J R Berger
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

10.  A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.

Authors:  Christina M Marra; Natasa Rajicic; David E Barker; Bruce A Cohen; David Clifford; M Judith Donovan Post; Armando Ruiz; Brian C Bowen; Meei-Li Huang; Jennie Queen-Baker; Janet Andersen; Sue Kelly; Sharon Shriver
Journal:  AIDS       Date:  2002-09-06       Impact factor: 4.177

View more
  9 in total

1.  Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience.

Authors:  C Buckle; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

2.  Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome.

Authors:  Michael N Khoury; Sarah Gheuens; Long Ngo; Xiaoen Wang; David C Alsop; Igor J Koralnik
Journal:  Brain       Date:  2013-10-01       Impact factor: 13.501

Review 3.  Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.

Authors:  Justin M Honce; Lidia Nagae; Eric Nyberg
Journal:  Mult Scler Int       Date:  2015-09-21

4.  High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients.

Authors:  Claudia Godi; Enrico De Vita; Enrico Tombetti; Indran Davagnanam; Lewis Haddow; Hans Rolf Jäger
Journal:  Eur Radiol       Date:  2017-02-06       Impact factor: 5.315

5.  Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients.

Authors:  Alessia Bianchi; Paolo Ragonese; Maria Aurelia Banco; Sabrina Realmuto; Giulia Vazzoler; Erika Portera; Giuseppe La Tona; Giuseppe Salemi
Journal:  eNeurologicalSci       Date:  2020-05-17

Review 6.  Clinical applications of diffusion weighted imaging in neuroradiology.

Authors:  Marta Drake-Pérez; Jose Boto; Aikaterini Fitsiori; Karl Lovblad; Maria Isabel Vargas
Journal:  Insights Imaging       Date:  2018-05-30

Review 7.  "CHOICES": An acronym to aid in delineating potential causes of non-metabolic, non-infectious acute toxic leukoencephalopathy.

Authors:  Yasemin Koksel; Can Ozutemiz; Jeffrey Rykken; Frederick Ott; Zuzan Cayci; Mark Oswood; Alexander M McKinney
Journal:  Eur J Radiol Open       Date:  2019-06-28

8.  Understanding progressive multifocal leukoencephalopathy: links between milky-way appearance and mismatch T2/FLAIR.

Authors:  Emiliano Ruiz Romagnoli; Manuel Perez Akly; Luis A Miquelini; Jorge Funes; Tatiana Gillanders; Cristina Besada
Journal:  Neuroradiol J       Date:  2021-05-28

9.  Isolated posterior fossa involvement of progressive multifocal leucoencephalopathy in HIV: A case series with review of the literature.

Authors:  Adziambei Mudau; Farhana E Suleman; Clara M Schutte; Zarina I Lockhat
Journal:  SA J Radiol       Date:  2017-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.